AI-powered Real-time Monitoring and Early Warning System for Hemodialysis
Technology Introduction:
This system is an integrated, multi-module AI platform for hemodialysis, incorporating heart failure risk prediction, dry-weight recommendation, hemoglobin (Hb) prediction, and a newly introduced intradialytic hypotension (IDH) prediction module in 2025. It continuously analyzes approximately 200 dialysis parameters with millisecond-level processing speed, providing real-time risk assessment and early warnings during treatment. The platform has been clinically deployed across 90 dialysis beds at Taipei Veterans General Hospital, with prospective data collection ongoing for validation.
Industry Applicability:
Taiwan has more than 90,000 dialysis patients, representing a substantial and ongoing healthcare need. Real-time AI prediction can help mitigate acute complications and reduce overall costs. The system has already been deployed in clinical practice and is positioned for nationwide scaling and international adoption. Musheng Technology is leading efforts toward SaMD certification and commercialization, through software licensing and technology transfer, with the goal of accelerating adoption and establishing the system as a compliant, market-ready AI solution to enhance dialysis safety.
This system is an integrated, multi-module AI platform for hemodialysis, incorporating heart failure risk prediction, dry-weight recommendation, hemoglobin (Hb) prediction, and a newly introduced intradialytic hypotension (IDH) prediction module in 2025. It continuously analyzes approximately 200 dialysis parameters with millisecond-level processing speed, providing real-time risk assessment and early warnings during treatment. The platform has been clinically deployed across 90 dialysis beds at Taipei Veterans General Hospital, with prospective data collection ongoing for validation.
Industry Applicability:
Taiwan has more than 90,000 dialysis patients, representing a substantial and ongoing healthcare need. Real-time AI prediction can help mitigate acute complications and reduce overall costs. The system has already been deployed in clinical practice and is positioned for nationwide scaling and international adoption. Musheng Technology is leading efforts toward SaMD certification and commercialization, through software licensing and technology transfer, with the goal of accelerating adoption and establishing the system as a compliant, market-ready AI solution to enhance dialysis safety.
Industrial Applications:
-
Taipei Veterans General Hospital
Taipei Veterans General Hospital was founded at this present address of Taipei Shipai on 1 January 1958. With an initial of 600 beds, it has now expanded to nearly 3,000 beds to regard as a National Medical Center. The Hospital established the Taichung Branch in 1982, Kaohsiung Branch in 1990, “Ta Wo Clinic” at Wolong Street, Taipei in 1998, started to manage Guandu Hospital as entrusted by Taipei City Government in 2000, and listed seven Veterans Hospitals at Suao, Yuanshan, Taoyuan, Hsinchu, Taitung, Yuli and Fenglin as the branches under its jurisdiction in 2011 to 2013. The Hospital is still expanding its services but without forgetting to extend its care in remote areas. The difficulties and grueling pioneering works that the predecessors have done are the greatest motivation and encouragement to me.
Contact Information
Name：-
Tel：02-2875-7264 #68901
Address：No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, Taiwan 11217,
Additional Information
Pavilion：Future Tech Artificial Intelligence FD15
Exhibiting Entity：National Science and Technology Council
Application Category：Information and Communications
More
Pavilion：Future Tech Artificial Intelligence FD15
Exhibiting Entity：National Science and Technology Council
Application Category：Information and Communications
Patents：
M653347
